One more that should take Michael Hubels advice....
From Script:
"First, while by definition they tend to be very rare – affecting fewer than 5 in 10,000 people in the EU and less than 200,000 people in the US – the 7,000 known orphan diseases affect up to 8% of the world's population which includes some 25 million US citizens and 30 million Europeans. This is more than the numbers suffering from cancer or cardiovascular disease," added Dr Wilson. .... According to Dr Wilson, the chance of successfully developing a drug for a rare disease is twice as high as for one targeting a common disease. "
Dr Shelagh Wilson is vice-president of business development, GSK Rare Diseases
0 comments:
Post a Comment